Alberta Investment Management Corp Agenus Inc Transaction History

Alberta Investment Management Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Oct 26, 2020	SELL	$2.98 - $5.2 $83,738 - $146,120	-28,100 Closed	0 $0
Q2 2020 Aug 11, 2020	BUY	$2.29 - $4.24 $64,349 - $119,144	28,100 New	28,100 $110,000
Q4 2019 Feb 14, 2020	SELL	$2.41 - $4.4 $153,276 - $279,840	-63,600 Closed	0 $0
Q3 2019 Oct 23, 2019	SELL	$2.17 - $3.14 $63,581 - $92,002	-29,300 Reduced 31.54%	63,600 $164,000
Q2 2019 Aug 14, 2019	BUY	$2.53 - $3.04 $175,582 - $210,976	69,400 Added 295.32%	92,900 $279,000
Q1 2019 May 15, 2019	BUY	$2.51 - $3.73 $58,984 - $87,655	23,500 New	23,500 $70,000

2.07M

Ticker AGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 283,163,008
Market Cap $4.73B
Description
Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...

Get notified when there are updates to the investment portfolio of Alberta Investment Management Corp, based on Form 13F filings with the SEC.

Stay updated on Alberta Investment Management Corp with notifications on news.